Human Albumin Injection is a sterile intravenous solution containing purified human serum albumin, a vital plasma protein responsible for maintaining blood volume and oncotic pressure. It is widely used in hospitals and critical care settings to restore circulating blood volume, manage hypoalbuminemia, and support patients with severe liver disease, burns, trauma, and major surgeries.
Medizalbu Human Albumin 20% Injection is a premium-quality albumin solution designed to provide effective plasma volume expansion and albumin replacement in clinically indicated patients. Manufactured under stringent quality standards, Medizalbu is trusted by healthcare professionals for its safety, purity, and consistent therapeutic performance.
Medizalbu is a 20% Human Albumin Injection intended for intravenous administration under the supervision of qualified healthcare professionals. Human albumin plays a crucial role in transporting hormones, fatty acids, bilirubin, and medicines while maintaining plasma oncotic pressure and fluid balance.
It is used in hospitals, ICUs, emergency departments, transplant centers, and specialty healthcare facilities where rapid plasma volume restoration is required.
Medizalbu Human Albumin 20% Injection is commonly used for the following medical conditions:
Patients with significantly low serum albumin levels due to liver disease, kidney disorders, malnutrition, burns, or critical illness may require albumin replacement therapy to restore normal protein levels and reduce edema.
Restores serum albumin levels
Reduces tissue swelling
Improves circulatory function
Supports recovery
Human Albumin Injection is widely used in patients with advanced liver disease to improve circulatory function and prevent complications associated with ascites and large-volume paracentesis.
Maintains blood volume
Supports liver disease management
Reduces circulatory dysfunction
Improves patient stability
In patients experiencing hypovolemic shock caused by trauma, surgery, burns, or severe blood loss, Medizalbu helps restore plasma volume and improve blood circulation.
Rapid plasma expansion
Improved tissue perfusion
Better hemodynamic stability
Supports emergency management
Severe burn injuries often result in significant plasma protein loss. Human Albumin Injection helps replace lost proteins and restore intravascular fluid volume.
Replaces plasma proteins
Maintains fluid balance
Supports burn recovery
Reduces complications
During and after major surgical procedures, patients may experience fluid shifts and reduced plasma volume. Albumin infusion assists in maintaining adequate circulation and tissue perfusion.
Patients admitted to intensive care units often require albumin replacement for managing hypotension, sepsis, trauma, and multiple organ dysfunction.
Human Albumin Injection helps maintain adequate blood volume and supports organ perfusion in critically ill patients when clinically appropriate.
Patients with nephrotic syndrome or severe protein loss through the kidneys may require albumin replacement therapy to improve plasma protein levels and reduce edema.
Human Albumin Injection is an effective plasma volume expander used in emergency and critical care settings where rapid intravascular volume restoration is necessary.
Effective plasma volume expansion
Helps manage hypoalbuminemia
Supports liver disease treatment
Useful in burn and trauma care
Restores oncotic pressure
Improves circulatory stability
Hospital-grade sterile formulation
Manufactured under stringent quality standards
Suitable for critical care applications
Human albumin maintains oncotic pressure by drawing fluid into the bloodstream from surrounding tissues. This action helps restore circulating blood volume, improve blood pressure, enhance organ perfusion, and transport essential substances throughout the body.
The dosage of Medizalbu Human Albumin 20% Injection depends on:
Patient's body weight
Clinical condition
Severity of albumin deficiency
Blood volume status
Physician's assessment
The injection should only be administered intravenously by trained healthcare professionals in a hospital or clinical setting.
Before administering Human Albumin Injection, healthcare professionals should evaluate:
Cardiac function
Kidney function
Fluid balance
Electrolyte status
Blood pressure
Risk of fluid overload
Continuous monitoring during infusion is recommended.
Like all intravenous medicines, Human Albumin Injection may occasionally cause:
Fever
Chills
Nausea
Headache
Skin rash
Allergic reactions
Temporary changes in blood pressure
Infusion site discomfort
Patients should immediately inform their healthcare provider if severe reactions occur.
Store according to the manufacturer's recommendations.
Do not freeze.
Protect from excessive heat and direct sunlight.
Use only if the solution is clear and the container is intact.
Medizalbu is manufactured with a strong focus on quality, safety, and consistency. It is suitable for hospitals, healthcare institutions, distributors, and pharmaceutical partners seeking reliable Human Albumin Injection products.
Sterile intravenous formulation
Reliable therapeutic performance
Strict quality control standards
Suitable for hospital procurement
Available for bulk supply and institutional requirements
Human Albumin Injection plays a vital role in managing hypoalbuminemia, liver disease, burns, shock, surgery, kidney disorders, and critical care conditions. Medizalbu Human Albumin 20% Injection provides dependable albumin replacement and plasma volume expansion when prescribed by healthcare professionals. Its quality-focused manufacturing and clinical reliability make it a trusted choice for hospitals and healthcare providers.
Disclaimer: This article is for educational purposes only and should not replace professional medical advice. Human Albumin Injection should only be used under the supervision of a qualified healthcare professional and according to approved prescribing information.